Specialty × MAC Jurisdiction Intelligence
DermatologyCMS & MAC AlertsPalmetto GBA · Jurisdictions JJ, JM
Every CMS transmittal, Palmetto GBA LCD revision, Federal Register notice, and OIG alert affecting Dermatology billing teams in Georgia, North Carolina, South Carolina, Tennessee, Virginia, West Virginia. Signal-scored and updated daily.
Active alerts
12
Critical / High
3
MAC jurisdiction
JJ, JM
Highest-risk CPT
CPT 99214
Recent Dermatology alerts under Palmetto GBA
3 of the 12 most recent Dermatology reimbursement alerts are Critical/High-severity for Palmetto GBA (Jurisdictions JJ, JM) billing teams. Each links to the source CMS/MAC document with the codes to review and the action to take.
- LCD L33563: Incision and Drainage (I & D) of Abscess of Skin, Subcutaneous and Accessory Structures — Wellpoint FederalNational Government Services · Jul 24, 2026
- FDA Approval: DUPIXENT (DUPILUMAB) — Type 1 - New Molecular EntityJul 23, 2026
- FDA Approval: ILUMYA (TILDRAKIZUMAB-ASMN) — Type 1 - New Molecular EntityJul 23, 2026
- FDA Approval: USTEKINUMAB (USTEKINUMAB) — Type 1 - New Molecular EntityJul 18, 2026
- FDA Approval: ELOCON (MOMETASONE FUROATE) — Type 3 - New Dosage FormJul 10, 2026
- FDA Approval: ELOCON (MOMETASONE FUROATE) — Type 3 - New Dosage FormJul 10, 2026
- FDA Approval: ELOCON (MOMETASONE FUROATE) — Type 1 - New Molecular EntityJul 10, 2026
- FDA Approval: ZORYVE (ROFLUMILAST) — Type 3 - New Dosage FormJul 8, 2026
- FDA Approval: ANZUPGO (DELGOCITINIB) — Type 1 - New Molecular EntityJul 8, 2026
- FDA Approval: CIBINQO (ABROCITINIB) — Type 1 - New Molecular EntityJul 8, 2026
- FDA Approval: LITFULO (RITLECITINIB) — Type 1 - New Molecular EntityJul 8, 2026
- FDA Approval: SOTYKTU (DEUCRAVACITINIB) — Type 1 - New Molecular EntityJul 8, 2026
Signal intelligence — Dermatology × Palmetto GBA
Highest-risk CPT code
CPT 99214
Office visit, established patient, moderate complexity
View full CPT alert profilePalmetto GBA jurisdiction
JJ, JM
Covers Georgia, North Carolina, South Carolina, Tennessee, Virginia, West Virginia. Every dermatology LCD revision, CMS transmittal, and Federal Register notice affecting these states is signal-scored and surfaced here daily.
View all 12 active alerts for Dermatology under Palmetto GBA
Full alert text, action recommendations, effective date deadlines, MAC LCD links, and signal score rationale — updated daily.
About Palmetto GBA (Jurisdictions JJ, JM)
Palmetto GBA is the Medicare Administrative Contractor responsible for processing Medicare Part A and Part B claims in Jurisdictions JJ, JM, covering Georgia, North Carolina, South Carolina, Tennessee, Virginia, West Virginia.Palmetto GBA issues Local Coverage Determinations (LCDs) that define coverage criteria, ICD-10-CM diagnosis code requirements, and CPT billing guidelines for Dermatology procedures within its jurisdiction. CLV Intelligence monitors Palmetto GBA's LCD publication feed, provider bulletin archives, and CMS contractor-specific transmittals daily.
Dermatology alerts in other MAC jurisdictions
Get weekly Dermatology alerts for Palmetto GBA — free
No credit card required. Unsubscribe any time.
Frequently asked
- What are the recent CMS updates for Dermatology under Palmetto GBA MAC?
- According to CLV Intelligence data, updated July 24, 2026, there are currently 12 active CMS and MAC reimbursement policy alerts for Dermatology under Palmetto GBA (Jurisdictions JJ, JM). Of these, 3 are classified Critical or High priority based on signal scoring of source authority, effective-date urgency, and document type. Alerts originate from Palmetto GBA Local Coverage Determinations (LCDs), CMS transmittals, Federal Register proposed and final rules, and OIG compliance publications. CLV Intelligence monitors all Palmetto GBA publications daily and assigns a signal score (0–100) to surface the changes most likely to affect coding accuracy and reimbursement.
- How many active audit alerts exist for Dermatology CPT codes under Palmetto GBA?
- According to CLV Intelligence data, 12 active reimbursement and policy alerts currently affect Dermatology CPT codes monitored under Palmetto GBA (Jurisdictions JJ, JM). 3 of these alerts carry a Critical or High signal score, indicating elevated compliance risk or near-term effective dates requiring timely coding review. The highest-risk CPT code currently flagged in the Dermatology alert set is CPT 99214 (Office visit, established patient, moderate complexity), which appears in Palmetto GBA LCD and CMS billing guidance revisions. CLV Intelligence cross-references each alert against the HCPCS and CPT code sets to surface procedure-level exposure for Dermatology billing teams.
- Which MAC jurisdiction covers Dermatology billing for practices in the Palmetto GBA region?
- Palmetto GBA administers Medicare Part A and Part B claims for practices in Jurisdictions JJ, JM. For Dermatology providers, Palmetto GBA issues Local Coverage Determinations (LCDs) that define coverage criteria, billing requirements, ICD-10-CM diagnosis code ranges, and CPT procedure code guidelines applicable to Medicare claims in its jurisdiction. According to CLV Intelligence data, Palmetto GBA monitors 12 open Dermatology alerts as of July 24, 2026. Practices in the Palmetto GBA jurisdiction should monitor LCD revisions at Palmetto GBA's provider portal and through aggregated daily alerting services such as CLV Intelligence.
- Is CPT 99214 currently under CMS or MAC review for Dermatology?
- According to CLV Intelligence data, CPT 99214 (Office visit, established patient, moderate complexity) is currently flagged as a high-signal procedure code within the Dermatology alert set monitored under Palmetto GBA (Jurisdictions JJ, JM). CMS and MAC contractors regularly review high-volume procedure codes for coverage criteria changes, NCCI edit revisions, medical necessity documentation requirements, and fee schedule adjustments. CLV Intelligence assigns CPT 99214 an elevated signal score based on the volume and recency of policy documents referencing this code. Dermatology coding teams should review the latest Palmetto GBA LCD and CMS transmittals affecting CPT 99214 before claim submission to avoid denials or post-payment audits.